 definitely swag and I definitely want to start off now that we got you back on the show and maybe you can start off by telling us a little bit about what's going on with psych wellness since you're on the show last yeah we've had two really big announcements for us first off with a change on the board Chris Hazleton was a board member who who joined us from the shell so Duncan Park Holdings was the shell that we did our reverse transaction with he was great he stayed on for the first year to transition but you know we've been looking to diversify our board and and add someone who had really strong financial background that could head up the audit committee and help us as we go forward so I had worked with Janine Stadolsky previously she was a partner at MMP head of client services for Grant Thornton so very very well healed in the in the financial and accounting background but she's also a fantastic networker so she's got incredible contacts throughout the Canadian business scene which will be beneficial for us as we go forward as well so she joined us the board and we'll take on the head of the audit committee for us as well so we're very pleased to have her very good so you're putting building blocks in place building your management building your board which is always a really really good thing to do when you're building a business now the last time we discussed how psychedelic companies right now are really running on speculation because there's really no revenue yet for the most part because of the fact that they have no revenue can you tell us how psych wellness is different in that you guys are working on a faster path to revenue yeah so I think that's definitely one of the unique sort of differentiators between psych wellness and some of our peers you know the path we chose out of the gate was to go and work with legal psychedelic compounds and that's when we identified Amity to Muscaria which is the red and white mushroom cap that we work with so it is a psychedelic mushroom and a psychedelic qualities however it has never been classified as a psychedelic drug as a scheduled one drug so that allows us to do the work with it and import export to our R&D but it also then allows us to go to market with a product so at the end of 2021 we'll be applying to the FDA for a new dietary ingredient and Health Canada for natural health product number and in the first half of 2022 we will begin marketing our product in both of those markets so our path to revenue and our path to to market is considerably shorter than our peer group for sure so we're talking about a year to revenue so even though we're talking about a company right now that is going to be moving to revenue sooner than a lot of other psychedelic stocks it's still a year away so I want to make sure everybody understands that this is still a very early stage story this is not a story that has revenue yet but as an investor and this is something I'm constantly trying to educate our community about as an investor would you like to get in early and wait or would you like to chase the green once it starts to explode you have to decide as an investor for me my strategy is I like to get in a company I really like do the research see that in the future it could be a dollar two dollars three dollars down the road and buy it at 30 cents and just sit on it that's my strategy that's the way most investors on Bay Street and on Wall Street and on House Street invest would you agree yeah I think so for sure especially you know there's there's two segments right so the institutional crowd they're going to wait they're going to wait till the stories de-risk the wait till our for by and large the wait till the pre-clinical trials are completed we've made that application and that's typically when you get institutional money coming in sort of that 100 million plus market cap at this stage you know you know we're trading in that 35 40 million market cap the opportunity now is you know we believe we've de-risked it considerably and one one of the developments that happened we we announced that we've filed our provisional application with a provisional patent application with the USPTO for our proprietary extract technology and protocols so you know we we trademarked AME-1 as the the name for the extraction of muskmal from emanate to muscaria and and now we're putting that wrapping the IP around it to protect you know the work that we've done and to protect their shareholders and add more value to the company so you know we spent about a year during the r&d getting to the point that we could get here and now we look at what's happening in the sector rich you see a lot of a lot of our peers there seems to be a bit of a patent frenzy happening where people are trying to protect that so although we are the only company that we're aware of working with emanate to muscaria and specifically muskmal we felt it was still important to do the work and file those provisional patents so that we can protect you know the shareholder base and the value that we create by doing that let's get into that emanate to muscaria and muskmal what makes this so special because i've had a lot of people message me and say i love what you're doing with psych wellness i love that product specifically i keep hearing it what makes it so special why does everybody love it so much because it is a very unique product so we all recognize it right that's the red and white mushroom cap we recognize it from pulp culture they've done a fantastic job for us in in making people aware of this mushroom super mario brothers super mario brothers alice in wonderland yeah so there's and in most children's books if you look at anything where there's sort of fairies and mysticals there's there's usually that mushroom as well so what we need to do as a company is is educate people on what emanate to muscaria is you know if you look at a lot of the psychedelic industry they'll use that mushroom to depict the psychedelic mushroom and people assume it's a psilocybin magic mushroom when in fact it's emanate to muscaria and the psychoactive compound is muskmal so we're in a process now we've got a great opportunity where people recognize it now we need to rebrand it in the fact of teaching people what emanita is and there's been some fantastic work by you know the grassroots community there's a huge community of people who are very passionate about emanita muscaria anecdotally they talk about the benefits of muskmal whether it be for ptsd sleep insomnia drug addiction helping with Lyme disease there's all sorts of anecdotal stories of how this fantastic mushroom has helped people so we're we're proud to be part of that you know we're working with we'd like to work with those communities because they've done a lot of great work they continue to and you know from our perspective we're doing the science side where at the end of our studies we're going to actually validate what they've been saying for for years about the benefits of this of this mushroom and and providing them with the science to back that up so we're really excited about it I think muskmal has you know very similar opportunities that we see with with other psychedelic compounds for serious mental and physical health issues and you know as we proceed with the company we'll be looking to look at those things as well so let's talk about mushrooms just like cannabis which has a massive community of people that really believe in it's and in how it helps people let's just put it like that and it helps people in so many ways pain anxiety depression you name it cannabis helps in so many ways another miracle drug and another conversation for another day now we're talking about mushrooms what is it that mushrooms does so I'm going to give you my opinion what I've heard I'm not an expert but from people that I know that have been in the industry they're telling me that you can take these mushrooms and your fears your problems your buried issues come to your forefront they literally just start coming to you like magic they start popping up like popcorn so are you able to deal with your problems more effectively and more efficiently this is groundbreaking this is revolutionary because you know I'm watching Vikings it's a show on Netflix I don't know if you've watched it but they're eating mushrooms yeah eating mushrooms they're dancing around everyone's having a good time they're seeing things so on television you're not really getting a really great idea of what that's going to do for you because they make it seem like cannabis kind of like you take this drug and you get all weird right but the reality is there's actually something very clinically special that's happening here with mushrooms and can you explain what it's doing to you when you take these mushrooms and what type of effects and how it's helping people because I don't think a lot of people really understand that this is true medicine and it's it's it's like nothing else on earth would you agree no for sure and I think that's what's so important about the way this whole sector is moving forward one of the major differentiators and I think we touched on it last time we spoke is that cannabis started with a bunch of entrepreneurs who were you know bootstrapping trying to get it going and eventually it caught and it became a massive industry psychedelics is starting off with the biggest money in the world backing it Peter Thiel you know Warren Buffett these guys are investing in a Thai life compass pathways to smaller degrees you've got you know and not much in order but you've got mind meds and and new me's field trips and psych wellness of the world each one is working on identifying different potential from these compounds for people's mental health and and the great thing that you know as you said so much is important and you're looking at sort of ayahuasca uh psilocybin dnt those type of compounds where the set and setting is so important and that's why you see companies where they're we're doing not just the compound but they're doing the therapy experience as well because you need to go through that process with someone that can help guide you because you are the way I look at it is cannabis has done a good job CBD has done a good job helping people with anxiety and doing and working with that but it's more like a band-aid where the mushrooms and the compounds in this space are actually instead of covering up and healing a wound they're allowing you to sort of open the wound extract the issue and then cleanse and remove so allows you to sort of stuff that we bury in our subconscious that sort of pokes up every once in a while causes challenges to our day-to-day lives we're allowed we're this is allowing us to sort of in a safe place safe environment pull that out deal with it and then you can move on you're not just covering it up and having it flare up every once in a while you're just you're being able to deal with that issue um you know you bring up the vikings and that's pretty cool for me because the vikings are said to have used actual amonita mascaria in their ceremonies and they would use that before because the difference between amonita and muskmal versus psilocybin um you know we we work on your GABA A receptor it's a different experience you're not having that introspective sort of trippy experience you're you know it's almost similar to being inebriated to some extent you get into people talk about these fantastic deep sleeps in a sleep state where you feel like you've been wrapped up in a warm blanket and sort of coddled through it and there's all kinds of great anecdotal experience from that we're really looking at it you know we've got professor david nut on our board and he's very passionate about the how it affects the brain and brain imagery and how we can help people with mental health issues so we're looking at it more from that side but uh no i think it's i think it's incredible what we're going to see happening over the next three to five years as these clinical trials move from phase two phase three and get approval and we start you know a tied life for example that's supposed to go public uh in the next month or two i believe they just raised 140 150 million dollars at a two billion dollar valuation so i'm hearing i was talking with the with henry at the conscious fund uh and and richard over there and i believe that they're targeting going three to four billion dollars as they go public so it's going to dwarf compass it's going to be the largest one but think about what that does for a sector when compass pathways went public mainstream media was all over the sector psychedelics you know rewiring your brain resetting your brain helping people getting rid of opioids working with these groups so i think the rising tide is going to lift all the ships this is a massive catalyst for the sector you know we're excited i think you know when you look at it from a perspective of how does that affect psych wellness well we're in that horizon psychedelic index fund now if you're new to the space and you're not really sure how to get involved you see all this mainstream media attention you hear people talking about the tie compass pathways how do you get exposure to that well now you can buy this basket so i think that's going to really benefit us as we're part of that basket of buying that happens uh and additionally i think as we continue to educate people on emanita what we're doing in the power of a me dash one which is our our protocol our extraction i think it's it's going to be a very exciting year ahead for sure is there any have we found any side effects have we've seen any like okay so for example i don't know if you've seen this but mike tyson on youtube yeah takes four grams right he puts it in his hand and he's on the joe uh the logan paul podcast and he's live on television on youtube in front of millions of people and he takes four grams a handful and just eats it and then he sits there and he's looking at a bird and he's all like he's in a good space right um it's becoming more and more mainstream where celebrities like mike tyson are feeling comfortable enough to eat four grams in front of the world this is becoming more and more mainstream like cannabis is and he openly smokes cannabis too and now he's openly taking mushrooms is there any long-term side effects can you overdose on mushrooms had have you found any information on that because obviously it's medicinal it's not being used for recreational yet so is there a reason for that are they saying okay if you take too much this could happen have we found any side effects of overdosing or what do we call macro dosing are there any side effects to that or do you know of any those are great questions and i think you know two things are happening so that type of experience that you see mike tyson doing you know it helps sort of remove stigma it doesn't really help on the on the medicinal side of things because it is he's doing that more in a recreational way he's he's doing it for a trip and and and you know if you're if you're going to do a macro trip typically you want to do that again set and setting with an environment with someone who can help you through those challenges and you want to determine in advance of that what it is you're trying to work through so that you can sort of guide yourself through it we what we do understand especially with emanita is that it affects different people differently and set and settings important and and the dosage is important as well what we do also understand is you know we do not believe scientifically that these are addictive compounds so that's a key thing when you look at using one of these natural occurring compounds to replace an opioid for people's treatments you're not using one product and creating a new problem of addiction to solve another problem you're using a product that can help them with it they can go deep you can do the work but you're not going to end up addicted to it people have used them recreationally for decades so i think it's silly for us to say there is no rep market they have been using them since the 60s and that's you know it was a political agenda to make them a scheduled one drug because of the whole you know civil rights movement and the vietnam war and everything that was happening i look at it and i think right now where we are it's just so important to just focus on the medicinal side we've got big money we've got big farm and we've got eyeballs you can change stigma you can remove the stigma and then and then you can look at sort of how it works on a micro dosing level because people are doing you probably know people that micro dose yourself i oh yeah i've been doing it myself popular people are making them at home yeah yeah so it's you know it's so that's another great question i was speaking with there's a woman named emanita dreamer who has a youtube channel and she's very passionate she's got a great following and i'm actually going to go on and talk to her because there was a lot of concern about psych wellness coming in and how are we going to you know we're going to destroy the ecosystem that exists now with with the emanita community um you know the way i look at it is there's people who like to make make their own wine and they enjoy that experience and they will continue to do it regardless of the fact there's a liquor store at the end of the street where they could go buy a nice bottle and then there's people who just go to the liquor store because they appreciate wine both sides appreciate wine they appreciate the feeling just you do it in a different manner to get there so you know i look at it as we work in unison with these other groups and and again the science that we're doing will help validate all the hard work that they've done over the years and prove that you know this is a safe product for human consumption and standardizing it to some degree where we can say here here's the protocols you follow these protocols and you're going to have a safe end result so it's it's exciting i think the whole sector is is going to change as we see these developments and i think from from your viewer's audience perspective there's going to be a tremendous amount of opportunity to look at i'm aware of just talking with the guys at the csc there's probably 40 companies that are trying to go public in the next four to six months in the sector we're proud and happy to be sort of ahead of all of that because you know we we sort of are allowed the opportunity to create our brand and and and get established where we're not competing with so much noise but i think we're going to see a lot of great stuff come out over the next three to five years for sure yeah i definitely you guys are being able to take advantage of first mover advantage how can accompany your position create interest in institutional investors you touched on a little bit the institutional investors need the price to go a little higher so what's the strategy now to get their attention yeah so two things that were key for us obviously we're thrilled to be included in the horizon index the psychedelic index that that's a stamp of approval where people said oh we we should actually look at emini to muscaria muskmal there's something behind it and then having having really credible people on the team you know building up a strong board having professor nut terry booth you know mike neiderhoff nick cadish myself and and then janine joining the board as well so now you've got you've got really high level professionals who have reputational risk attached to anything that they do and they don't do it just for the sake of a couple options they do it because they believe in it so that's key having a strong advisory board and then you know working with banks so we did that bot deal with can accord in my mind like i spent 15 16 years institutional sales and trading prior to coming to the issuer side so i've seen the mistakes that management teams have made where they don't engage the street they don't pay the street they don't they don't engage the investment community and that's why when when the opportunity to work with you came up i was so excited because having access to speak directly to your community is important they need to understand that there's a person there who cares about what he's doing and cares about what they're saying as a shareholder so engagement and as you do all of those things properly you set yourself up organically where you become one of the names on the list these institutions are looking at because you built up liquidity if you don't have liquidity in your stock nobody cares so you have to be a you have to show that you've got liquidity you're achieving milestones you've got a team that people can feel comfortable backing and then you know the product they got to believe that what you're working on has an opportunity and we're working on something that has you know billion dollar market when you look at the global mental health opportunity so i think we're putting checkmarks in all the boxes and then again it's just continuing to stay in front of everyone and and delivering the message and educating on emanita for us is the key jeff i have a question from one of our audience members jeffrey let's who's also part of our trading club seems to me that the canadian government cfda likes psychedelics is the canadian government giving any pushback so where we're where we live going on the food supplement and the health supplement side we're pretty lucky because we don't have to deal in those channels um you know i'm a i'm a seed investor in another company that's working on mdma i'd love to introduce you to these guys as they get closer um you know they're working on getting a license to produce manufacture and sell mda for for the clinical trials and they're going through those processes now and and so yeah they're very much involved they're very supportive they just want to make sure that is done properly and and ensure that the products that are coming out um you know are safe and and it all comes down to safety and then effectively it comes down to revenue as well so a way for them to be able to generate revenue through taxes and stuff and licenses uh jeff also says i take a lion's mane extract and my cognitive thinking has improved leaps and balance so another example of how people are taking this recreationally or maybe medicinally and they're starting to feel like it's taking the stress off it's taking the edge off like they've got these stresses they take the psychedelics they go through a period of time where they're going through the process i guess it's i've heard six to eight hours maybe uh maybe as little as a couple hours depending on how much you how much of a dose you take and then the next day they feel great they feel like the stress is gone they feel like they've removed some of that that barrier and they're able to move on with their life better this is what i'm hearing from person after person after person and i just keep thinking myself this is pretty wonderful like it's unbelievable like why did we take so long for us to get here well there's some great anecdotal stories of people having success with it in that fashion for sure and i think what jeff's talking about is more on the functional side with lion's mane and reishi and quarter seps and and that's a huge market like paul stan has done a fantastic job you know he's the godfather of the fungi really and he's done a fantastic job creating that platform and building that brand that other people are able to use now and and get their products out we look at it you know we're we're singularly focused right now just because we think we have something very special with anna nita um but you know i look at it as the the trifecta of the functional mushrooms so there'd be a functional mushroom like a quarter sep or a lion's mane needs to be edible and it needs to have some underlying health benefits and those are sort of the key definitions that you say for a functional mushroom where i look at anna nita historically it has been consumed in europe in asia and it's consumed still today when you do the process properly you have to boil it per boil it to remove to reduce the i butanic acid but it's consumed as a food now uh you know underlying health benefits there's decades and and in centuries really of it being used through ceremony and people using it recently more more recently for for some of those issues that we talked about anecdotally for limes disease or or for depression or for uh sorry not depression but addiction and then it is psychoactive so i look at it and say okay edible underlying health benefits psychoactive it's kind of the trifecta we've got the three legs of the stool and i think that's really special um and you know when i was talking with our board when we brought janine on and talking to some of the guys i really strongly feel that there's a bit of a target on us right now i think where you look at the sector you've got massive amounts of money that have been raised i think numy just raised another 35 million dollars yeah field trips totally cashed up mine that's totally cashed up and they're sitting with you know two three billion dollar market caps two three hundred and billion dollar market caps plus um i think we're going to see cost consolidation happen in the sector similar to what we saw with cannabis because you get to a point where you've created incredible shareholder value um and you're sitting on a large cash position but you're three to five years out on clinical trials how do you keep how do you feed the beast being the market how do you keep that news flow going how do you keep that interest going so i think we're going to start to see some consolidation in the sector my concern is that you know we add a very unique piece being a path to market quickly with a legal psychedelic um a lot of the science already approved uh you know stamped off by the inclusion into the index you know filing our patents doing our preclinicals so i'm really you know nervous not like listen it's a happy problem but you want to if something happens you want it to be at the peak right so we're trying to do what we can to to keep that interest in the share price and try to get it higher so that we're not picked off opportunistically and uh but i do think you know not just ourselves i think you'll see some of these other smaller psychedelic companies that have some really unique approaches to things and are working on some patents or something different about uh you know how it's delivered or how it's you know shortening the time as you mentioned a four to six hour trip well if you can do something where that condenses down to like a 40 minute experience but you still are able to go deep and have that with a clinician uh therapist there's value in that so there's some really neat things happening and uh you know from our perspective we uh you know we just want to keep the gas pedal down uh do as much as we can to share with the investment community what we're working on so they can see the value and uh and drive the company forward if there was one thing you would want shareholders to know today about psych wellness what would it be ah well just one thing well we're very passionate about what we're doing we think we have a very unique situation with being the only company working with amity to muscaria in the public company sphere there's likely some in the private sphere now that are starting i haven't heard that but i i know that you know bay street is great at copycats and when they see an opportunity and something will come so uh we have a first mover advantage we're working with a legal psychedelic mushroom and we're very passionate about bringing this to market and uh and creating basically a new a new sort of subsector of the market where we can sell this because it is unique there's nothing on the market like it if there was an investor or a partner or a joint venture opportunity and somebody wanted to get in contact with you jeff what's the best way to reach you yeah for sure well listen all my contact information's on the press releases so obviously there our website um you know i pick up emails phone calls text message whatsapp some on all those platforms you've introduced me to telegram and uh and getting on that so uh you know at 40 turning 48 this year learning some of this new stuff but uh no listen i'm always happy to engage with investors or interested parties and you know the way i look at it there's never a wasted conversation um you know because from from everything you learn something so absolutely well thank you for joining us CEO of psyched wellness jeff stevens ps yc in canada ps ycf in america if you guys like this video please smash the like button comment down below share the video and subscribe feel free to contact jeff if you guys have a question and remember rich tv live is strictly for education and entertainment purposes always do your due diligence always do your research before you invest in anything that we talk about go and consult a financial advisor chances are your financial advisors say where you got the pick you can say from my boy rich and your financial your financial advisor is going to say that's a really good pick i really like this pick as a long-term play i think the future is bright thank you so much for joining us today jeff and continue your great work thanks very much pleasure and look forward to staying in touch always a pleasure love to have you back on the show again soon if you guys are not winning you're not watching we bring you the winners and we bring them to first put psych wellness on your watch list i think it's undervalued underappreciated underexposed at these levels keep keep it up on your watch list and thank you guys for watching have yourselves a great day everybody this is rich from rich tv live and i'm out have a nice day peace